Table 13.
Inhibitor | Structure | Potency | Reported target | Reference |
---|---|---|---|---|
Compound 2 | 1.6 µM | KAT2B | (Zeng et al., 2005) | |
Ischaemin (MS120) | 19 µM | CREBBP | (Borah et al., 2011) | |
I-BET-762 (GSK525762A) | 50–60 nM | BRD2, BRD3, BRD4, BRDT | (Nicodeme et al., 2010) | |
I-BET-151 (GSK1210151A) | 250–800 nM | BRD2, BRD3, BRD4, BRDT | (Seal et al., 2012) | |
JQ1 | 50–90 nM | BRD2, BRD3, BRD4, BRDT | (Filippakopoulos et al., 2010) | |
RVX-208 | 40 nM – 3 µM | BRD2, BRD3, BRD4, BRDT | (Khmelnitsky et al., 2013) |